Huron Consulting Group (NASDAQ:HURN) Releases FY 2024 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 5.600-6.100 for the period, compared to the consensus estimate of 5.650. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Huron Consulting Group also updated its FY24 guidance to $5.60-6.10 EPS.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on HURN shares. StockNews.com downgraded Huron Consulting Group from a buy rating to a hold rating in a research report on Wednesday, February 28th. Barrington Research lifted their target price on Huron Consulting Group from $128.00 to $133.00 and gave the company an outperform rating in a research report on Wednesday, March 6th.

Huron Consulting Group Price Performance

Shares of Huron Consulting Group stock traded down $0.44 during trading hours on Tuesday, hitting $93.24. The company’s stock had a trading volume of 153,217 shares, compared to its average volume of 118,551. The business has a 50 day moving average price of $96.21 and a two-hundred day moving average price of $100.59. Huron Consulting Group has a 12-month low of $70.66 and a 12-month high of $113.31. The company has a market cap of $1.72 billion, a PE ratio of 29.14 and a beta of 0.58. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.32 and a current ratio of 1.32.

Huron Consulting Group (NASDAQ:HURN) last posted its earnings results on Tuesday, February 27th. The business services provider reported $1.29 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.17. The company had revenue of $339.23 million for the quarter, compared to the consensus estimate of $341.71 million. Huron Consulting Group had a return on equity of 17.77% and a net margin of 4.47%. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.12 earnings per share. Analysts expect that Huron Consulting Group will post 5.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Huron Consulting Group

In other Huron Consulting Group news, Director John Mccartney sold 300 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $98.13, for a total transaction of $29,439.00. Following the sale, the director now directly owns 56,919 shares in the company, valued at $5,585,461.47. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, Director John Mccartney sold 300 shares of the stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $98.13, for a total value of $29,439.00. Following the sale, the director now directly owns 56,919 shares in the company, valued at $5,585,461.47. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director James H. Roth sold 6,804 shares of the stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $95.00, for a total value of $646,380.00. Following the completion of the sale, the director now owns 62,825 shares in the company, valued at $5,968,375. The disclosure for this sale can be found here. Insiders have sold a total of 42,080 shares of company stock worth $4,146,076 over the last ninety days. Company insiders own 2.20% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.